Pegaptanib
Indication
Age-related macular degeneration (NICE TA155)
NICE TA 155 - Ranibizumab and pegaptanib for the treatment of age-related macular degeneration
Black
Brand:
Nice TA:
155
Commissioning responsibility:
CCG
PbR excluded:
Yes
BNF chapter:
Eye
Background
Recommendation
LSCMMG Recommendation:
Black
Reason for decision:
Not recommended for prescribing on the NHS in Lancashire & South Cumbria
Supporting documents: